✦ LIBER ✦

Low-grade Bone Lesions in Survivors of Childhood Medulloblastoma/Primitive Neuroectodermal Tumor

✍ Scribed by Koral, Korgun; Roy, Dave; Timmons, Charles F.; Gargan, Lynn; Bowers, Daniel C.

Book ID: 121809036
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 776 KB
Volume: 19
Category: Article
ISSN: 1076-6332
DOI: 10.1016/j.acra.2011.08.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

No preferential parent of origin for the

No preferential parent of origin for the isochromosome 17q in childhood primitive neuroectodermal tumor (medulloblastoma)

✍ Jaclyn A. Biegel; Erica Wentz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 2 views

We have shown that an i(17q) is the most frequent abnormality in central nervous system primitive neuroectodermal tumors (PNETs; medulloblastoma), implicating the presence of a tumor suppressor gene which maps to 17p. In the present study, we investigated whether the deletion of chromosome arm 17p t

4120 POSTER Low Bone Mineral Apparent De

4120 POSTER Low Bone Mineral Apparent Density in Childhood Survivors of Medulloblastoma

✍ Karas, O.; Konoplya, N. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Thyroid dysfunction as a late effect in

Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/Primitive neuroectodermal tumors : A comparison of hyperfractionated versus conventional radiotherapy

✍ Daisy Chin; Charles Sklar; Bernadine Donahue; Naveen Uli; Nancy Geneiser; Jeffre 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

## Background: Primary hypothyroidism is a common sequela of craniospinal radiotherapy in the treatment of pediatric brain tumors. ## Methods: The authors compared the incidence of primary hypothyroidism after hyperfractionated radiotherapy (hfrt) (n = 14 patients) versus conventionally fractiona

Vasoactive intestinal peptide (VIP) and

Vasoactive intestinal peptide (VIP) and VIP receptors: Gene expression and growth modulation in medulloblastoma and other central primitive neuroectodermal tumors of childhood

✍ Michael C. Frühwald; M. Sue O'Dorisio; Julie Fleitz; Torsten Pietsch; Jean Claud 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB 👁 2 views

Vasoactive intestinal peptide (VIP) is a neuromodulator and growth regulator in the developing nervous system. We analyzed 10 primitive neuroectodermal tumor (PNET) cell lines, 29 central PNET (cPNET) and 17 tumors of the Ewing's sarcoma/peripheral PNET family (ESFT) using reverse transcriptase-poly

A phase II study of the farnesyl transfe

A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: A children's oncology group study

✍ Maryam Fouladi; H. Stacy Nicholson; Tianni Zhou; Fred Laningham; Kathleen J. Hel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

## Abstract ## BACKGROUND. An open‐label Phase II study of tipifarnib was conducted to evaluate its safety and efficacy in children with recurrent or refractory medulloblastoma (MB)/primitive neuroectodermal tumor (PNET), high‐grade glioma (HGG), and diffuse intrinsic brainstem glioma (BSG). ## M